DK1726310T3 - Lægemiddel til cancerterapi - Google Patents

Lægemiddel til cancerterapi

Info

Publication number
DK1726310T3
DK1726310T3 DK05720394.5T DK05720394T DK1726310T3 DK 1726310 T3 DK1726310 T3 DK 1726310T3 DK 05720394 T DK05720394 T DK 05720394T DK 1726310 T3 DK1726310 T3 DK 1726310T3
Authority
DK
Denmark
Prior art keywords
drug
lactoferrin
cancer therapy
antibody
cancer
Prior art date
Application number
DK05720394.5T
Other languages
English (en)
Inventor
Kiyohiko Hatake
Yasuhito Terui
Yuji Mishima
Akio Yamada
Takuma Sakurai
Takehito Itoh
Original Assignee
Morinaga Milk Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morinaga Milk Industry Co Ltd filed Critical Morinaga Milk Industry Co Ltd
Application granted granted Critical
Publication of DK1726310T3 publication Critical patent/DK1726310T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Polymers & Plastics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK05720394.5T 2004-03-19 2005-03-09 Lægemiddel til cancerterapi DK1726310T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004080454 2004-03-19
PCT/JP2005/004123 WO2005089788A1 (ja) 2004-03-19 2005-03-09 癌治療のための薬剤

Publications (1)

Publication Number Publication Date
DK1726310T3 true DK1726310T3 (da) 2012-05-07

Family

ID=34993444

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05720394.5T DK1726310T3 (da) 2004-03-19 2005-03-09 Lægemiddel til cancerterapi

Country Status (14)

Country Link
US (1) US7419667B2 (da)
EP (1) EP1726310B1 (da)
JP (1) JP3998702B2 (da)
KR (1) KR100773259B1 (da)
CN (2) CN101444624B (da)
AT (1) ATE541581T1 (da)
AU (1) AU2005224209B2 (da)
CA (1) CA2533753C (da)
DK (1) DK1726310T3 (da)
ES (1) ES2381189T3 (da)
HK (2) HK1128113A1 (da)
NZ (1) NZ544448A (da)
PT (1) PT1726310E (da)
WO (1) WO2005089788A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2587727A1 (en) * 2004-11-19 2006-05-26 Jagat Rakesh Kanwar Methods of immune or haematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer
EP2094274A4 (en) * 2006-12-21 2011-05-11 Biokine Therapeutics Ltd T-140 PEPTIDE ANALOGUE WITH CXCR4 SUPERAGONIST ACTIVITY FOR BONE MARROW RECOVERY
EP2197471A2 (en) * 2007-09-11 2010-06-23 Mondobiotech Laboratories AG Use of the peptides maippkknqdk (cow kappa casein 106-116) and/or ygfqna (serorphin) as therapeutic agents
JP5715622B2 (ja) 2009-06-14 2015-05-07 バイオカイン セラピューティックス リミテッド 血小板レベルを増大させるためのペプチド療法
EP2841084B1 (en) 2012-04-24 2018-05-30 Biokine Therapeutics Ltd. Cxcr4 antagonist peptide for use in the treatment of large cell lung cancer
KR101455306B1 (ko) * 2012-07-17 2014-10-27 엘에스엠 주식회사 세포 증식 촉진용 사람 락토페린의 펩신 가수분해물 및 이의 제조 방법
WO2016056665A1 (ja) * 2014-10-08 2016-04-14 学校法人慶應義塾 白血球の細胞外トラップ形成の阻害剤
KR20180063881A (ko) 2015-07-16 2018-06-12 바이오카인 테라퓨틱스 리미티드 암 치료용 조성물 및 방법
JP7461620B2 (ja) 2015-10-06 2024-04-04 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ 治療用化合物及び方法
KR102033920B1 (ko) 2016-02-23 2019-10-18 바이오라인알엑스 리미티드 급성 골수성 백혈병을 치료하는 방법
CN113354726B (zh) * 2021-06-11 2022-12-27 南方科技大学 乳铁蛋白活性肽及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6351337A (ja) 1986-08-22 1988-03-04 Snow Brand Milk Prod Co Ltd 抗腫瘍剤
JPS63186260A (ja) 1987-01-28 1988-08-01 Minolta Camera Co Ltd 作像装置
JP2818056B2 (ja) 1990-09-07 1998-10-30 森永乳業株式会社 抗菌性ペプチドおよび抗菌剤
JP3110078B2 (ja) * 1991-06-21 2000-11-20 森永乳業株式会社 高純度抗菌性ペプチドの大量製造法
EP0629347B1 (en) * 1992-01-23 1997-07-02 Morinaga Milk Industry Co., Ltd. Antibacterial agent and treatment of article therewith
JP3207647B2 (ja) 1993-12-21 2001-09-10 森永乳業株式会社 ＩｇＧおよびＩｇＭクラスの抗体産生を促進する免疫賦活剤
JP3738042B2 (ja) 1994-05-17 2006-01-25 森永乳業株式会社 非経口用抗腫瘍剤
JP3506274B2 (ja) 1994-09-01 2004-03-15 雪印乳業株式会社 新規ペプチドおよび免疫賦活剤
JP3693377B2 (ja) 1995-04-20 2005-09-07 森永乳業株式会社 生体内で感染防御作用を有するペプチド混合物と、このペプチド混合物を含有する組成物
JPH1059864A (ja) * 1996-08-15 1998-03-03 Morinaga Milk Ind Co Ltd 経口がん転移抑制剤
US6333311B1 (en) * 1997-02-03 2001-12-25 Pharming Useful properties of human lactoferrin and variants thereof
GB9818938D0 (en) * 1998-08-28 1998-10-21 Alpharma As Bioactive peptides
JP2000229881A (ja) 1999-02-10 2000-08-22 Morinaga Milk Ind Co Ltd 癌疾患の予後改善剤

Also Published As

Publication number Publication date
JPWO2005089788A1 (ja) 2008-01-31
CN1838965B (zh) 2011-07-06
KR100773259B1 (ko) 2007-11-05
PT1726310E (pt) 2012-04-27
ES2381189T3 (es) 2012-05-23
EP1726310A1 (en) 2006-11-29
ATE541581T1 (de) 2012-02-15
CA2533753A1 (en) 2005-09-29
CN1838965A (zh) 2006-09-27
WO2005089788A1 (ja) 2005-09-29
CA2533753C (en) 2012-10-16
CN101444624A (zh) 2009-06-03
NZ544448A (en) 2009-10-30
KR20060095899A (ko) 2006-09-04
AU2005224209B2 (en) 2007-04-19
EP1726310A4 (en) 2009-06-24
US7419667B2 (en) 2008-09-02
JP3998702B2 (ja) 2007-10-31
US20060204501A1 (en) 2006-09-14
HK1128113A1 (en) 2009-10-16
EP1726310B1 (en) 2012-01-18
HK1093436A1 (en) 2007-03-02
AU2005224209A1 (en) 2005-09-29
CN101444624B (zh) 2012-10-10

Similar Documents

Publication Publication Date Title
DK1726310T3 (da) Lægemiddel til cancerterapi
DE602006014990D1 (de) Intranasale verabreichung von schnell wirkendem insulin
NO2017028I2 (no) eftrenonacog alfa eller et biotilsvarende legemiddel ihht Artikkel 10(4) av Directive 2001/83/EC, som beskyttet av basispatentet.
LTPA2017009I1 (lt) Brutono tirozinkinazės inhibitoriai
PH12013502286A1 (en) Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)
EA200801164A2 (ru) Ингибиторы протеина, активирующего 5-липоксигеназу (flap)
EP2331072A4 (en) METHODS AND COMPOSITIONS FOR ORAL PROTEIN DELIVERY
EA201000584A1 (ru) Ингибиторы протеина, активирующего 5-липоксигеназу (flap)
AR063149A1 (es) Formulaciones a base de polipeptidos estables
NO20065227L (no) Menoklonale antistoff mot hepatocytt vekstfaktor
HUP0500560A2 (hu) Mikróbás enzimek új keverékei
BR0312506A (pt) Composições transdérmicas de toxina botulìnica
EA200602137A1 (ru) Гидрогелевые препараты интерферона
HK1109876A1 (en) Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation
WO2007087154A3 (en) Methods for enhancing therapeutic effects of a neurotoxin
GB2453491A (en) Immunogenic proteins of burkholderia pseudomallei and uses thereof
EA201691018A1 (ru) Фармацевтическая композиция, содержащая смесь проферментов и ферментов
DK1763363T3 (da) Farmaceutiske præparater indeholdende diaminooxidase
SE0301663D0 (sv) Analysmetod för infusionsläkemedel
EA200800722A1 (ru) Средство, активирующее стволовые клетки и/или клетки-предшественники
WO2005116197A3 (en) Adamts-8 proteins and uses thereof
ATE453388T1 (de) Calciumtrifluoroacetat zur bereitung antiangiogenetischer arzneimittel
MX2021004754A (es) Enzimas de degradacion de cistina/cisteina de primates modificadas por ingenieria genetica para usos terapeuticos.
MXPA02008989A (es) Tratamiento con enzimas proteoliticas de enfermedades respiratorias obstructitvas de aves.
ATE552839T1 (de) Pharmazeutische verwendung von immunologisch mit diphtherie-toxin korrelierten proteinmolekülen